JHancock Classic Value C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
John Hancock Classic Value Fund Class C JCVCX
- NAV / 1-Day Return 20.80 / 0.00
- Total Assets 523.7M
-
Adj. Expense Ratio
1.860%
- Expense Ratio 1.890%
- Distribution Fee Level Average
- Share Class Type Level Load
- Category Mid-Cap Value
- Investment Style Mid Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 1.09%
- Turnover 13%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 3:34 AM GMT+0
Morningstar’s Analysis JCVCX
Will JCVCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 42.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Baxter International Inc | 6.62 | 36M | Healthcare |
Humana Inc | 5.20 | 28M | Healthcare |
CVS Health Corp | 4.59 | 25M | Healthcare |
Fresenius Medical Care AG ADR | 4.18 | 22M | Healthcare |
Dollar General Corp | 3.80 | 20M | Consumer Defensive |
MetLife Inc | 3.80 | 20M | Financial Services |
Corebridge Financial Inc | 3.64 | 20M | Financial Services |
Global Payments Inc | 3.56 | 19M | Industrials |
Wells Fargo & Co | 3.49 | 19M | Financial Services |
Magna International Inc | 3.45 | 19M | Consumer Cyclical |
United States